1. Home
  2. CFLT vs TECH Comparison

CFLT vs TECH Comparison

Compare CFLT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Confluent Inc.

CFLT

Confluent Inc.

HOLD

Current Price

$30.09

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$58.68

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFLT
TECH
Founded
2014
1976
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
9.5B
IPO Year
2021
1989

Fundamental Metrics

Financial Performance
Metric
CFLT
TECH
Price
$30.09
$58.68
Analyst Decision
Buy
Strong Buy
Analyst Count
33
14
Target Price
$30.21
$71.23
AVG Volume (30 Days)
17.1M
1.7M
Earning Date
10-27-2025
11-05-2025
Dividend Yield
N/A
0.55%
EPS Growth
N/A
N/A
EPS
N/A
0.49
Revenue
$1,113,149,000.00
$1,216,732,000.00
Revenue This Year
$22.76
$2.33
Revenue Next Year
$16.57
$7.05
P/E Ratio
N/A
$120.22
Revenue Growth
21.57
3.85
52 Week Low
$15.64
$46.01
52 Week High
$37.90
$79.28

Technical Indicators

Market Signals
Indicator
CFLT
TECH
Relative Strength Index (RSI) 78.69 41.76
Support Level $22.91 $58.75
Resistance Level $30.23 $61.20
Average True Range (ATR) 0.54 2.02
MACD 0.88 -0.49
Stochastic Oscillator 98.41 2.94

Price Performance

Historical Comparison
CFLT
TECH

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: